AGM Information • Apr 18, 2024
AGM Information
Open in ViewerOpens in native device viewer
If you are in any doubt as to any aspect of the proposals referred to in the document or about the action you should take, you are recommended to seek your own independent advice immediately from your stockbroker, bank manager, solicitor, accountant or other appropriately authorised independent professional adviser who is authorised under the Financial Services and Markets Act 2000 if you are in the United Kingdom or, if not, from another appropriately authorised independent adviser.

(Registered in Gibraltar with registered number 90099)
NOTICE OF 2024 ANNUAL GENERAL MEETING
Registered office: Suite 601/701 Europort Europort Road Gibraltar
Registered in Gibraltar with registered number 90099
If you are in any doubt as to any aspect of the proposals referred to in the document or about the action you should take, you are recommended to seek your own independent advice immediately from your stockbroker, bank manager, solicitor, accountant or other appropriately authorised independent professional adviser who is authorised under the Financial Services and Markets Act 2000 if you are in the United Kingdom or, if not, from another appropriately authorised independent adviser.
If you have sold or transferred all your ordinary shares (the "Ordinary Shares") or underlying depositary interests (the "Depositary Interests") in 888 Holdings Plc ("888" or the "Company"), you should pass this letter and all other documents enclosed with it to the purchaser or transferee or to the stockbrokers, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee as soon as possible.
Notice of the Annual General Meeting (the "Meeting") of 888 to be held at 9.00am UK time (10.00am Gibraltar time) on Monday 13 May 2024 is set out on pages 7 and 8 of this document.
The Meeting will take place at the office of Hudson Sandler LLP at 25 Charterhouse Square, London EC1M 6AE. Shareholders not able to attend in person will be able to follow the proceedings of the Meeting over the online Investor Meet Company platform by registering in advance via the following link:
https://www.investormeetcompany.com/888-holdings-plc/register-investor
Shareholders are invited to submit any questions in respect of the business of the Meeting for the Board to consider. Questions may be submitted in advance or during the Meeting over the Investor Meet Company platform following registration, and the Board will aim to respond to any such questions relevant to the business of the Meeting.
A live broadcast of the Meeting will be opened over the platform at approximately 8.55am UK time (9.55am Gibraltar time) on 13 May 2024. Shareholders joining over the platform will be able to see and hear the Meeting, but will not be seen or heard by the Board.
888 Holdings Plc is committed to reducing paper and improving efficiency in its shareholder communications. As was the case last year, you will not receive a hard copy Form of Proxy or Form of Direction for the 2024 AGM in the post automatically. You may request a hard copy Form of Proxy or Form of Direction directly from our Registrar, Link Group. Details of how to request, and complete a hard copy Form of Proxy and Form of Direction are set out in the notes on page 9 of this document. All instructions must be received by the Registrars by no later than 9.00am UK time (10.00am Gibraltar time) on 8 May 2024 for the Form of Direction and 9.00am UK time (10.00am Gibraltar time) on 9 May 2024 for the Form of Proxy.
Shareholders can complete the Form of Proxy or Form of Direction electronically by logging on to https://www.signalshares.com. Further details are set out in the notes on page 9.
Shareholders wishing to vote at the Meeting are strongly encouraged to do so by completing a Form of Proxy or Form of Direction as appropriate. SHAREHOLDERS WILL NOT BE ABLE TO VOTE AT THE MEETING OVER THE ONLINE PLATFORM.
The Board encourages shareholders to watch the Company's website and regulatory news services for any updates in relation to the Meeting that may need to be provided.
A Form of Proxy should be completed electronically by logging on to https://www.signalshares.com as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 9 May 2024. Alternatively, a Form of Proxy may be requested from the Registrar, Link Group, and should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 9 May 2024.
A Form of Direction should be completed by Depositary Interest Holders and Employee Shareholders only electronically by logging on to https://www.signalshares.com as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 8 May 2024. CREST members may instruct the Depositary how to vote the shares underlying their Depositary Interests by using the electronic voting service. Alternatively, a Form of Direction may be requested from the Registrar, Link Group, and should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 8 May 2024.
LinkVote+ is a free app for smartphone and tablet provided by Link Group (the Company's Registrar). It offers shareholders the option to submit a proxy appointment quickly and easily online, as well as real-time access to their shareholding records. The app is available to download on both the Apple App Store and Google Play.
If you are an institutional investor, you may also be able to appoint a proxy electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io.
Suite 601/701 Europort Europort Road Gibraltar
18 April 2024
To:
Our 2024 Annual General Meeting will be held on Monday 13 May 2024 at 9.00am UK time (10.00am Gibraltar time). The Meeting location will be the office of Hudson Sandler LLP at 25 Charterhouse Square, London EC1M 6AE.
The directors of the Company (the "Directors") strongly encourage you to fill in the Form of Proxy if you are an Ordinary Shareholder, or if you are Depositary Interest Holder or Employee Shareholder, the Form of Direction. Please see "Action to be taken" below for further details.
The Notice convening the Meeting is set out on pages 7 and 8 and I am writing to give you details of the items of business to be transacted at the Meeting.
The business of the Meeting will be to consider and if, thought fit, pass the resolutions set out on pages 7 and 8.
These resolutions deal with the Annual Report & Accounts 2023 (Resolution 1), the Directors' Remuneration Report (Resolution 2), and the Remuneration Policy (Resolution 3). These resolutions will be proposed as ordinary resolutions.
These resolutions deal with the election and re-election of Directors. These resolutions will be proposed as ordinary resolutions.
These resolutions deal with the appointment of the auditors and the auditors' remuneration (Resolutions 12 and 13), and the Directors' authority to allot shares (Resolution 14). All these resolutions will be proposed as ordinary resolutions.
These resolutions deal with the authority for the Company to purchase its own shares (Resolution 15), and the authority of the Directors to disapply pre-emption rights, in line with UK institutional shareholder guidelines (Resolutions 16 and 17). These resolutions will be proposed as special resolutions.
The Board recommends to shareholders a change in name of the Company to evoke plc and that the Memorandum and Articles of Association be updated to reflect the new Company name.
An explanation of each of the resolutions is set out on pages 4 to 6 of this document.
Your Board unanimously recommends that shareholders vote in favour of all the resolutions set out in this Notice of the Meeting, which they consider to be in the best interests of the Company and the shareholders as a whole.
The Directors intend to vote in favour of all resolutions in respect of their beneficial shareholdings totalling 2,643,429 Ordinary Shares representing 0.6% of the issued share capital of the Company as at 29 February 2024 (being the latest practicable date prior to publication of this Notice).
Ordinary Shareholders are requested to complete a Form of Proxy indicating how they wish to cast their votes on each of the resolutions. Shareholders should complete the Form of Proxy electronically by logging on to https://www.signalshares.com as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 9 May 2024. Alternatively, a Form of Proxy may be requested from the Registrar, Link Group, and should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 9 May 2024.
Depositary Interest Holders or Employee Shareholders are requested to complete a Form of Direction indicating how they wish to cast their votes on each of the resolutions. A Form of Direction may be completed electronically by logging on to https://www.signalshares.com or it may be requested from the Registrar, Link Group. The Form of Direction should be completed and returned, in accordance with the instructions printed thereon, as soon as possible and by no later than 9.00am UK time (10.00am Gibraltar time) on 8 May 2024. Alternatively, CREST members may instruct the Depositary how to vote the shares underlying their Depositary Interests by using the electronic voting service.
Yours faithfully
Chairman
Resolutions 1 to 14 are proposed as ordinary resolutions. This means that for each of those resolutions to be passed, more than half of the votes cast must be in favour of the resolution. Resolutions 15 to 18 are proposed as special resolutions. This means that for each of those resolutions to be passed, at least three-quarters of the votes cast must be in favour of the resolution.
In accordance with the Gibraltar Companies Act, the Directors will present the Annual Report & Accounts for the financial year ended 31 December 2023 to the general meeting of shareholders.
The Directors' Remuneration Report for the financial year ended 31 December 2023 is set out on pages 66 to 82 of the Company's Annual Report & Accounts 2023.
As the Company is Gibraltar incorporated, it is not required to prepare a directors' remuneration report pursuant to the UK Directors' Remuneration Report requirements in Schedule 8 to the UK Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 (as amended) (the "DRR Regulations").
The Company has, however, prepared the Directors' Remuneration Report substantially in line with the requirements of the DRR Regulations on a voluntary basis as if the Company were required to do so, as a matter of good governance.
The shareholder vote on the Directors' Remuneration Report is advisory in nature and the Directors' entitlement to remuneration is not conditional on it. The Board will take the outcome of the vote into consideration in setting the Company's remuneration policy for its Directors.
Shareholders are requested to approve the Remuneration Policy set out on pages 66 to 71 of the Company's Annual Report & Accounts 2023.
As a company incorporated in Gibraltar, the Company is not bound by English law or regulation in the area of Directors' remuneration to the same extent that it applies to companies incorporated in England. However, as the Company is listed on the premium segment of the Official List of the FCA and traded on the main market for listed securities of the London Stock Exchange and reflecting the Directors' approach to good corporate governance, the Company has voluntarily adopted the disclosure and shareholder voting requirements of a UK incorporated company, as set out in Schedule 8 to the UK Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, and Section 439A of the UK Companies Act 2006.
Companies to which Section 439A of the UK Companies Act 2006 applies must put their remuneration policy to shareholders at least every three years, unless during that time it is to be changed. The Company intends to next submit its Remuneration Policy for approval by Shareholders in three years' time.
In accordance with the Company's Articles of Association, all Directors of the Company will retire at the Annual General Meeting and are offering themselves for election or re-election.
In proposing the election or re-election of the Directors, the Chairman has confirmed that, following formal performance evaluation, each individual continues to make an effective and valuable contribution to the Board and demonstrates commitment to the role.
Details of the Board evaluation process in relation to the Directors can be found on pages 49 and 50 of the Company's Annual Report & Accounts 2023.
Following a rigorous search process by the Nominations Committee, the Company seeks shareholder approval for the appointment of Per Widerström and Sean Wilkins as executive directors.
Biographical details of the current Directors are shown on pages 44 and 45 of the Company's Annual Report & Accounts 2023.
The Company's independent auditors must be appointed or reappointed each year at the Annual General Meeting.
Following a thorough tender process (as set out on page 61 of the Annual Report), the Directors propose that, the recommendation of the Audit & Risk Committee, Ernst & Young LLP and EY Limited, Gibraltar (together, "EY"), be reappointed as auditors, including for the purposes of meeting the Company's statutory requirements under Section 257 of the Gibraltar Companies Act, as amended, and the filing of the Company's financial statements in Gibraltar pursuant to Section 258 of the Gibraltar Companies Act 2014, as amended. EY has expressed its willingness to continue in office.
Resolution 13 authorises the Audit & Risk Committee to determine the auditors' remuneration.
Resolution 14 is proposed to renew the Directors' authority to allot relevant securities, in line with UK institutional shareholder guidelines. Paragraph (a)(i) of the resolution will allow the Directors to allot relevant securities up to a maximum nominal amount of £748,513.75 representing no more than one-third (33.33%) of the Company's Ordinary Share capital in issue as at 29 February 2024, being the latest practicable date prior to the publication of this Notice, such amount to be reduced by the nominal amount of any equity securities allotted under paragraph (a)(ii) in excess of £748,513.75. In accordance with institutional guidelines issued by The Investment Association, paragraph (a)(ii) of the resolution will allow Directors to allot, including the relevant securities referred to in paragraph (a)(i), further of the Company's shares in connection with a pre-emptive offer by way of a rights issue to up to a maximum nominal amount of £1,497,027.51, representing no more than two-thirds (66.66%) of the Company's Ordinary Share capital in issue as at 29 February 2024, being the latest practicable date prior to the publication of this Notice, such amount to be reduced by any relevant securities allotted under paragraph (a)(i).
This authority will expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2025.
The Directors have no present intention of exercising this authority. The Company does not hold any shares in treasury.
Resolution 15 is to authorise the Company to purchase its own shares.
Background to and reasons for the Company to purchase its own shares
In certain circumstances it may be advantageous for the Company to purchase its own shares. The Board considers it desirable for the general authority to purchase its own shares to be available to provide maximum flexibility in the management of the Company's capital resources.
Pursuant to its Memorandum and Articles of Association and Section 105 of the Gibraltar Companies Act, the Company has the power to purchase its own shares. The resolution to be proposed at the Meeting will enable the Company, subject to certain limitations, to purchase shares in the market for cancellation. This authority will expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2025, unless previously renewed, varied or revoked by the Company at a general meeting. Such authority would allow for purchases to be made on the terms set out in the resolution of up to a maximum number of 44,910,824 Ordinary Shares (representing no more than 10% of the issued Ordinary Share capital as at 29 February 2024, being the latest practicable date prior to the publication of this document).
The proposed maximum price (exclusive of expenses) which may be paid for each Ordinary Share will be the higher of: (i) an amount equal to 105% of the average of the middle market quotations of an Ordinary Share in the Company as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which the Ordinary Share is contracted to be purchased; and (ii) an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent bid for an Ordinary Share in the Company as derived from the London Stock Exchange Trading System. The proposed minimum permitted price (exclusive of expenses) which may be paid for an Ordinary Share will be the nominal value of an Ordinary Share of £0.005.
A purchase of the proposed maximum of 44,910,824 Ordinary Shares at the share price of £0.865 (the closing market price on 29 February 2024) would involve the Company in expenditure of approximately £38,847,862.76 before commissions, and at the proposed minimum price of £0.005 would involve the Company in the expenditure, on the same basis, of approximately £224,554.12 before commissions.
As at 29 February 2024, there were outstanding options to subscribe for a total of 2,785,932 Ordinary Shares in the Company, representing approximately 0.6% of the Company's issued share capital at that time. If the Company were to exercise in full the proposed authority to purchase its own shares and prior to such purchase the Company's issued share capital remained unchanged, the shares for which there are outstanding options to subscribe would represent approximately 0.7% of the Company's issued Ordinary Share capital, as reduced by those purchases. The Company does not hold any treasury shares as at 29 February 2024.
The Directors intend to use the general share purchase authority with discretion and purchases would only be made from funds not required for other purposes and in light of market conditions prevailing at the time and other investment opportunities. The Directors will use this authority only after careful consideration, taking into account the Company's cash resources and capital, appropriate gearing levels and the overall position of the Company. The Directors will only purchase such shares if satisfied that it was in the interest of the shareholders as a whole to do so and would result in an increase in earnings per share and would benefit shareholders generally. No announcement will be made by the Company in advance of market purchases, but any purchases made by the Company would be announced by 7.30am UK time (8.30am Gibraltar time) on the business day next following the transaction.
Any purchases of Ordinary Shares would be by means of market purchases through the London Stock Exchange. Such Ordinary Shares would be automatically cancelled.
Resolution 16 seeks to renew the Directors' authority to allot equity securities for cash without first offering them to existing shareholders, in line with the latest UK institutional shareholder guidelines. Under Articles 19–26 of the Company's Articles of Association, if the Directors wish to allot Ordinary Shares, or grant rights to subscribe for, or convert securities into, Ordinary Shares, they must in the first instance offer them to existing shareholders in proportion to their holdings. Apart from rights issues or any other pre-emptive offer concerning equity securities, the authority would allow the Directors to issue shares for cash up to a maximum aggregate nominal amount of £112,277.06 representing 22,455,411 Ordinary Shares (representing no more than 5% of the Company's Ordinary Share capital in issue as at 29 February 2024, being the latest practicable date prior to the publication of this Notice) without first being required to offer such shares to existing shareholders.
The Directors do not intend to issue more than 7.5% of the issued Ordinary Share capital of the Company for cash on a non-preemptive basis in any rolling three-year period (other than in connection with an acquisition or specified capital investment as described in the Pre-Emption Group's Statement of Principles) without prior consultation with shareholders.
This authority will expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2025, save that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Board may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired. The Directors have no present intention of exercising this authority.
Resolution 17 requests further shareholder approval, by way of a separate special resolution in line with the best practice guidance issued by the Pre-Emption Group, for the Directors to allot equity securities for cash without first being required to offer such securities to existing shareholders. The proposed resolution reflects the Pre-Emption Group Statement of Principles for the disapplication of pre-emption rights (the "Statement of Principles") and will expire on 30 June 2025 or at the conclusion of the next Annual General Meeting of the Company after the passing of this resolution, whichever is the earlier.
The authority granted by this resolution, if passed:
The authority granted by this resolution would be in addition to the general authority to disapply pre-emption rights under Resolution 15. The maximum nominal value of equity securities which could be allotted if both authorities were used would be £224,554.12 representing 44,910,824 Ordinary Shares, representing no more than 10% of the issued Ordinary Share capital of the Company as at 29 February 2024 (being the latest practicable date prior to publication of this Notice).
Under Resolution 18, pursuant to Section 29 of the Gibraltar Companies Act, and subject to the necessary regulatory approvals, consents, and compliance with applicable laws, the Board proposes that the name of the Company be changed from 888 Holdings plc to evoke plc.
The Group has undergone significant change since the acquisition of William Hill in 2022. To support this continuing evolution and to move forward with one corporate identity, the Board has considered the target operating model, value proposition, vision and brand for the Group as a whole. Our brands are highly recognised and respected globally, therefore we will maintain our three flagship consumer brands: 888, William Hill, and Mr Green. The Board believes this will provide the right structure to support our strategy and strengthen our identity in market.
Accordingly, the Group's Memorandum and Articles of Association will be updated to reflect the new Company name. The proposed new Memorandum and Articles of Association will also be available for inspection at the Annual General Meeting at least 15 minutes prior to the start of the Meeting and up until the close of the Meeting, and on the National Storage Mechanism following the conclusion of the Meeting.
NOTICE is hereby given that the Annual General Meeting of 888 Holdings plc will be held on Monday 13 May 2024 at 9.00am UK time (10.00am Gibraltar time) for the following purposes. The Meeting location will be the office of Hudson Sandler LLP at 25 Charterhouse Square, London EC1M 6AE.
14 THAT:
and so that the Directors may make such exclusions or other arrangements as they consider expedient in relation to treasury shares, fractional entitlements, record dates, shares represented by depositary receipts, legal or practical problems under the laws in any territory or the requirements of any relevant regulatory body or stock exchange or any other matter;
(b) this authority shall expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2025, save that, in each case, the Company may before such expiry make an offer or agreement which would or might require relevant securities to be allotted after such expiry and the Board may allot relevant securities in pursuance of such an offer or agreement as if the authority conferred hereby had not expired. All previous unutilised authorities will cease to have effect.
so that the Directors may make such exclusions or other arrangements as they consider expedient in relation to treasury shares, fractional entitlements, record dates, shares represented by depositary receipts, legal or practical problems under the laws in any territory or the requirements of any relevant regulatory body or stock exchange or any other matter; and
(b) to the allotment (otherwise than pursuant to sub-paragraph (a) above) of equity securities up to an aggregate nominal value of £112,277.06.
This authority shall expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2025, save that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Board may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired.
This authority shall expire upon the earlier of: (i) the conclusion of the next Annual General Meeting of the Company after passing this resolution; and (ii) 30 June 2025, save that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Board may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired.
18 THAT with effect from the conclusion of the Meeting and subject to the relevant to the necessary regulatory approvals, consents, and compliance with applicable laws, Company's name will be changed to evoke plc and the Company's Memorandum and Articles of Association will be updated to reflect the new name.
On behalf of the Board
Lord Jon Mendelsohn Chairman
18 April 2024


This page intentionally left blank
Suite 601/701 Europort Europort Road Gibraltar
Registered in Gibraltar with registered number 90099
Tel: +44(0) 800 029 3050
https://corporate.888.com/
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.